Should we develop screens for multi-drug antibiotic tolerance?
نویسندگان
چکیده
منابع مشابه
Should we reevaluate antibiotic breakpoints?
The breakpoints used to interpret antimicrobial susceptibility tests should be carefully determined initially, using microbiological, pharmacokinetic, pharmacodynamic, and clinical data, and then reevaluated periodically as changes in bacterial resistance, susceptibility test methods, or antibiotic formulations occur. Throughout the world, different governmental agencies and professional organi...
متن کاملHow long should we wait for functional dyspepsia to develop?
Improvement of social hygiene and decreased H. pylori prevalence has resulted in the decrease of gastric organic diseases such as gastric ulcers and/or cancers. However, the number of patients with dyspeptic symptoms does not seem to have decreased, probably due to increased life stress and complicated social structures. Accordingly the attention to functional dyspepsia is rapidly increasing, a...
متن کاملShould we stay or should we go?
With the potential benefit of positive movement in the housing market and now having two properties this may place you in a good position to increase your retirement nest egg if you choose to sell your family home when you downsize. Depending on your situation you may even be able to keep the family home as an investment. One of the biggest decisions for many retirees is whether to stay in the ...
متن کاملHow to develop better screens for anti-cancer therapies?
The clinical efficacy of chemotherapy relies in part on its ability to potentiate anti-tumor immune responses. Recent work shows that several chemotherapeutic drugs induce intra-tumoral expression of lymphocyte-attracting chemokines, leading to clinical responses. Here, we argue that such knowledge should be used to screen for novel anti-tumor treatments.
متن کاملWhy we should develop a regulated system of kidney sales: a call for action!
T he main argument in favor of a regulated system of payment to living kidney sellers is simple: Financial incentives will increase donation, so fewer of our waitlisted transplant candidates will die while waiting. Wait-list deaths are a relatively new and increasingly severe problem for patients with ESRD. As recently as the early 1980s, the average wait for a deceased donor (DD) kidney transp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Review of Anti-infective Therapy
سال: 2016
ISSN: 1478-7210,1744-8336
DOI: 10.1080/14787210.2016.1194754